XML 39 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Significant Accounting Policies - Additional Information (Detail)
$ in Millions
9 Months Ended
Aug. 29, 2025
USD ($)
Sep. 30, 2025
Segment
shares
Jun. 16, 2025
shares
Feb. 20, 2025
Dec. 31, 2024
shares
Accounting Policy [Line Items]          
Common Stock, Shares, Outstanding | shares   4,045,000     4,037,000
Common stock, shares authorized | shares   225,000,000 4,000,000   225,000,000
Number of reportable segment | Segment   1      
Reverse Stock Split [Member]          
Accounting Policy [Line Items]          
Reverse stock split   1-for-25      
Common Stock, Shares, Outstanding | shares     101,100,000    
FibroGen International [Member]          
Accounting Policy [Line Items]          
Discontinued operations name   FibroGen International      
Beijing Falikang Pharmaceutical Co Ltd | Beijing Kangda Yongfu Pharmaceutical Co., LTD [Member] | AstraZenecaAB [Member]          
Accounting Policy [Line Items]          
Percentage of outstanding shares acquired       51.10%  
Share Purchase Agreement [Member]          
Accounting Policy [Line Items]          
Discontinued operation consideration $ 220.4        
Share Purchase Agreement [Member] | FibroGen International [Member]          
Accounting Policy [Line Items]          
Discontinued operation consideration 220.4        
Discontinued operation consideration in cash 85.0        
Cash received for sale of discontinued operation 210.4        
Outstanding interest and related premium and fees 80.9        
Purchase price in cash 85.0        
Share Purchase Agreement [Member] | FibroGen International [Member] | CHINA          
Accounting Policy [Line Items]          
Discontinued operation consideration 220.4        
Discontinued operation consideration in cash 85.0        
Purchase price in cash 85.0        
Share Purchase Agreement [Member] | Net Cash Held in China [Member]          
Accounting Policy [Line Items]          
Discontinued operation consideration in cash 135.4        
Purchase price in cash 135.4        
Share Purchase Agreement [Member] | Net Cash Held in China [Member] | CHINA          
Accounting Policy [Line Items]          
Discontinued operation consideration in cash 135.4        
Purchase price in cash $ 135.4